Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Novel Therapy for Breast Cancer Survivors With Genitourinary Syndrome of Menopause

NCT05812924 is registered in ClinicalTrials.gov with University of Miami as lead sponsor.

NCT NCT05812924
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05812924 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Novel Therapy for Breast Cancer Survivors With Genitourinary Syndrome of Menopause
Lead sponsor
University of Miami
Phase
Phase 2
Overall status
Active, not recruiting
Start date
September 26, 2023
Completion date
September 30, 2026
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, genitourinary syndrome of menopause